ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,318.705
0.46%
Brent Oil
83.685
0.15%
Bitcoin
61,565.43
0.62%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Faron Pharmaceuticals Oy (FARN)

  7. Faron Pharmaceuticals Oy (FARN) News

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FARN
DateTimeSourceHeadlineSymbolCompany
03/05/202413:39Alliance NewsAlliance NewsTRADING UPDATES: Kelso raises stake in NCC; Transense joins projectLSE:FARNFaron Pharmaceuticals Oy
30/04/202414:00RNS Regulatory NewsFaron Pharmaceuticals Oy Update on financial statusLSE:FARNFaron Pharmaceuticals Oy
30/04/202413:00RNS Regulatory NewsFaron Pharmaceuticals Oy Board ChangeLSE:FARNFaron Pharmaceuticals Oy
16/04/202407:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron confirms plans under new leadershipLSE:FARNFaron Pharmaceuticals Oy
15/04/202410:58Alliance NewsAlliance NewsFaron Pharmaceuticals reappoints former finance chief on interim basisLSE:FARNFaron Pharmaceuticals Oy
15/04/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Financial OfficerLSE:FARNFaron Pharmaceuticals Oy
08/04/202411:50Alliance NewsAlliance NewsUPDATE: Faron Pharmaceuticals promotes COO to CEO as father retiresLSE:FARNFaron Pharmaceuticals Oy
08/04/202411:28Alliance NewsAlliance NewsFaron Pharmaceuticals promotes COO to CEO as founder steps backLSE:FARNFaron Pharmaceuticals Oy
08/04/202407:15Alliance NewsAlliance News*Faron Pharmaceuticals says Markku Jalkanen to retire as CEO in Q2 but remain board memberLSE:FARNFaron Pharmaceuticals Oy
08/04/202407:15Alliance NewsAlliance News*Faron Pharmaceuticals promotes COO Juho Jalkanen to CEO, starting May 1LSE:FARNFaron Pharmaceuticals Oy
08/04/202407:10RNS Regulatory NewsFaron Pharmaceuticals Oy Approval of Warrant Terms and ConditionsLSE:FARNFaron Pharmaceuticals Oy
08/04/202407:05RNS Regulatory NewsFaron Pharmaceuticals Oy Decisions of the Board of DirectorsLSE:FARNFaron Pharmaceuticals Oy
08/04/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Executive OfficerLSE:FARNFaron Pharmaceuticals Oy
05/04/202412:00RNS Regulatory NewsFaron Pharmaceuticals Oy Results of the Annual General MeetingLSE:FARNFaron Pharmaceuticals Oy
04/04/202411:58Alliance NewsAlliance NewsFaron Pharmaceuticals secures funding to deliver next "milestones"LSE:FARNFaron Pharmaceuticals Oy
04/04/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Announcement of PlacingLSE:FARNFaron Pharmaceuticals Oy
03/04/202410:59Alliance NewsAlliance NewsTRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exitLSE:FARNFaron Pharmaceuticals Oy
28/03/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Issue of Warrants to IPF Funding UpdateLSE:FARNFaron Pharmaceuticals Oy
26/03/202410:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron´s Annual Report 2023LSE:FARNFaron Pharmaceuticals Oy
18/03/202417:09Alliance NewsAlliance NewsLONDON MARKET CLOSE: Stocks downbeat before central bank rate stormLSE:FARNFaron Pharmaceuticals Oy
18/03/202411:41Alliance NewsAlliance NewsFaron Pharmaceuticals shares jump on positive data from Bexmab studyLSE:FARNFaron Pharmaceuticals Oy
18/03/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Additional Positive Data from Phase 1 of BEXMABLSE:FARNFaron Pharmaceuticals Oy
14/03/202407:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron to Host BEXMAB WebcastLSE:FARNFaron Pharmaceuticals Oy
13/03/202420:49Alliance NewsAlliance NewsEARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian dealLSE:FARNFaron Pharmaceuticals Oy
13/03/202414:00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Annual General Meeting 2024LSE:FARNFaron Pharmaceuticals Oy
13/03/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Financial Statement January 1 to December 31 2023LSE:FARNFaron Pharmaceuticals Oy
04/03/202419:59Alliance NewsAlliance NewsTRADING UPDATES: Beowulf raises funds for Kallak iron ore projectLSE:FARNFaron Pharmaceuticals Oy
04/03/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Binding commitments for convertible loansLSE:FARNFaron Pharmaceuticals Oy
28/02/202416:00RNS Regulatory NewsFaron Pharmaceuticals Oy Replacement - Update to 2024 Financial CalendarLSE:FARNFaron Pharmaceuticals Oy
27/02/202421:12Alliance NewsAlliance NewsTRADING UPDATES: Armadale Capital eyes Mahenge project financingLSE:FARNFaron Pharmaceuticals Oy
 Showing the most relevant articles for your search:LSE:FARN

Your Recent History

LSE
ALBA
Alba Mineral Resources
LSE
BOO
Boohoo
LSE
GGP
Greatland Gold
LSE
SCE
Surface Transforms
LSE
ENET
Ethernity Networks
LSE
GKP
Gulf Keystone Petroleum
LSE
NSCI
Netscientific
LSE
EDEN
Eden Research
LSE
RKH
Rockhopper Exploration
LSE
ALGW
Alpha Growth
LSE
MNL
Manchester & London Inve...
LSE
VAST
Vast Resources
LSE
ASC
Asos
LSE
PXC
Phoenix Copper
LSE
SBRY
Sainsbury (j)
LSE
JIM
Jarvis Securities
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved